Induction of a menopausal state alters the growth and histology of ovarian tumors in a mouse model of ovarian cancer

Menopause

Volumn 18, Issue 5, 2011, Pages 549-557

  Laviolette, Laura A ^a,b   Ethier, Jean François ^a,b   Senterman, Mary K ^c   Devine, Patrick J ^d   Vanderhyden, Barbara C ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

4 vinylcyclohexene diepoxide; Follicle stimulating hormone; Luteinizing hormone; Menopause; Mouse model; Ovarian cancer

Indexed keywords

4 VINYLCYCLOHEXENE DIEPOXIDE; ADENOVIRUS VECTOR; CRE RECOMBINASE; CYTOKERATIN 19; ESTROGEN RECEPTOR ALPHA; FOLLITROPIN; GONADOTROPIN; INDUSTRIAL CHEMICAL; INHIBIN A; LUTEINIZING HORMONE; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER MODEL; CARCINOGENESIS; CONTROLLED STUDY; EPITHELIUM; EPITHELIUM CELL; FEMALE; FOLLITROPIN BLOOD LEVEL; GRANULOSA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUTEINIZING HORMONE BLOOD LEVEL; MENOPAUSE; MOUSE; NONHUMAN; NUDE MOUSE; OVARIECTOMY; OVARY; OVARY CANCER; OVARY FOLLICLE; OVARY SURFACE EPITHELIUM; SERTOLI CELL; TRANSGENIC MOUSE;

ANIMALS; CELL LINE, TUMOR; CYCLOHEXENES; DISEASE MODELS, ANIMAL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MENOPAUSE; MICE; MICE, TRANSGENIC; OVARIAN FOLLICLE; OVARIAN NEOPLASMS; SERTOLI CELL TUMOR; SIMIAN VIRUS 40; VINYL COMPOUNDS;

EID: 79959973877     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181fca1b6     Document Type: Article

References (41)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96. (Pubitemid 351521864)
2. Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 1983;71:717-721. (Pubitemid 14232385)
3. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001;22:255-288. (Pubitemid 32458162)
4. Kurman RJ, Shih Ie M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010;34:433-443.
5. Medeiros F, Muto MG, Lee Y, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006;30:230-236. (Pubitemid 43740193)
6. Stewart SL, Querec TD, Gruver BN, O'Hare B, Babb JS, Patriotis C. Gonadotropin and steroid hormones stimulate proliferation of the rat ovarian surface epithelium. J Cell Physiol 2004;198:119-124. (Pubitemid 38120972)
7. Davies BR, Finnigan DS, Smith SK, Ponder BA. Administration of gonadotropins stimulates proliferation of normal mouse ovarian surface epithelium. Gynecol Endocrinol 1999;13:75-81. (Pubitemid 29273895)
8. Stewart SL, Querec TD, Ochman AR, et al. Characterization of a carcinogenesis rat model of ovarian preneoplasia and neoplasia. Cancer Res 2004;64:8177-8183. (Pubitemid 39491753)
9. Keri RA, Lozada KL, Abdul-Karim FW, Nadeau JH, Nilson JH. Luteinizing hormone induction of ovarian tumors: oligogenic differences between mouse strains dictates tumor disposition. Proc Natl Acad Sci U S A 2000;97:383-387. (Pubitemid 30055840)
10. Risma KA, Clay CM, Nett TM, Wagner T, Yun J, Nilson JH. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci U S A 1995;92:1322-1326.
11. Danilovich N, Roy I, Sairam MR. Ovarian pathology and high incidence of sex cord tumors in follitropin receptor knockout (FORKO) mice. Endocrinology 2001;142:3673-3684. (Pubitemid 32681779)
12. Gee DM, Flurkey K, Finch CE. Aging and the regulation of luteinizing hormone in C57BL/6J mice: impaired elevations after ovariectomy and spontaneous elevations at advanced ages. Biol Reprod 1983;28:598-607. (Pubitemid 13104986)
13. Mayer LP, Devine PJ, Dyer CA, Hoyer PB. The follicle-deplete mouse ovary produces androgen. Biol Reprod 2004;71:130-138. (Pubitemid 38915317)
14. Mayer LP, Dyer CA, Eastgard RL, Hoyer PB, Banka CL. Atherosclerotic lesion development in a novel ovary-intact mouse model of perimenopause. Arterioscler Thromb Vasc Biol 2005;25:1910-1916. (Pubitemid 41243462)
15. Romero-Aleshire MJ, Diamond-Stanic MK, Hasty AH, Hoyer PB, Brooks HL. Loss of ovarian function in the VCD mouse-model of menopause leads to insulin resistance and a rapid progression into the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 2009;297:R587-R592.
16. Schauwecker PE, Wood RI, Lorenzana A. Neuroprotection against excitotoxic brain injury in mice after ovarian steroid depletion. Brain Res 2009;1265:37-46.
17. Craig ZR, Davis JR, Marion SL, Barton JK, Hoyer PB. 7, 12-Dimethylbenz[a]anthracene induces Sertoli-Leydig-cell tumors in the follicle-depleted ovaries of mice treated with 4-vinylcyclohexene diepoxide. Comp Med 2010;60:10-17.
18. Crist KA, Zhang Z, You M, et al. Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7, 12-dimethylbenz[a]anthracene (DMBA) coated suture. Carcinogenesis 2005;26:951-957. (Pubitemid 41214324)
19. Hilfrich J. Comparative morphological studies on the carcinogenic effect of 7, 12-dimethylbenz (A) anthracene (DMBA) in normal or intrasplenic ovarian tissue of C3H mice. Br J Cancer 1975;32:588-595.
20. Krarup T. Effect of 9, 10-dimethyl-1, 2-benzanthracene on the mouse ovary. Ovarian tumorigenesis. Br J Cancer 1970;24:168-186.
21. Boutwell RK. The biochemistry of preneoplasia in mouse skin. Cancer Res 1976;36:2631-2635.
22. Marvanova S, Vondracek J, Penccikova K, et al. Toxic effects of methylated benz[a]anthracenes in liver cells. Chem Res Toxicol 2008;21:503-512.
23. Ledwith BJ, Joslyn DJ, Troilo P, et al. Induction of minisatellite DNA rearrangements by genotoxic carcinogens in mouse liver tumors. Carcinogenesis 1995;16:1167-1172.
24. Laviolette LA, Garson K, Macdonald EA, et al. 17A-Estradiol accelerates tumor onset and decreases survival in a transgenic mouse model of ovarian cancer. Endocrinology 2010;151:929-938.
25. Clark-Knowles KV, Garson K, Jonkers J, Vanderhyden BC. Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes. Exp Cell Res 2007;313:133-145. (Pubitemid 44958459)
26. Vandenbergh JG. Effect of the presence of a male on the sexual maturation of female mice. Endocrinology 1967;81:345-349.
27. Pectasides D, Pectasides E, Psyrri A. Granulosa cell tumor of the ovary. Cancer Treat Rev 2008;34:1-12. (Pubitemid 351181015)
28. Young RH. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Mod Pathol 2005;18:S81-S98. (Pubitemid 40188618)
29. Casagrande JT, Louie EW, Pike MC, Roy S, Ross RK, Henderson BE. BIncessant ovulation-and ovarian cancer. Lancet 1979;2:170-173.
30. Fathalla MF. Incessant ovulationVa factor in ovarian neoplasia? Lancet 1971;2:163.
31. Tourgeman DE, Lu JJ, Boostanfar R, Amezcua C, Felix JC, Paulson RJ. Human chorionic gonadotropin suppresses ovarian epithelial neoplastic cell proliferation in vitro. Fertil Steril 2002;78:1096-1099. (Pubitemid 35292515)
32. Ivarsson K, Sundfeldt K, Brannstrom M, Hellberg P, Janson PO. Diverse effects of FSH and LH on proliferation of human ovarian surface epithelial cells. Hum Reprod 2001;16:18-23. (Pubitemid 32058573)
33. Zhang M, Cheung MK, Shin JY, et al. Prognostic factors responsible for survival in sex cord stromal tumors of the ovaryVan analysis of 376 women. Gynecol Oncol 2007;104:396-400. (Pubitemid 46156957)
34. Chen VW, Ruiz B, Killeen JL, Cote TR, Wu XC, Correa CN. Pathology and classification of ovarian tumors. Cancer 2003;97:2631-2642. (Pubitemid 36539064)
35. Chan JK, Cheung MK, Husain A, et al. Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol 2006;108:521-528. (Pubitemid 44337091)
36. Behringer RR, Cate RL, Froelick GJ, Palmiter RD, Brinster RL. Abnormal sexual development in transgenic mice chronically expressing Müllerian inhibiting substance. Nature 1990;345:167-170.
37. Couse JF, Hewitt SC, Bunch DO, et al. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors α and β. Science 1999;286:2328-2331. (Pubitemid 30016891)
38. Stoica G, Koestner A, Capen CC. Testicular (Sertoli's cell)-like tumors of the ovary induced by N-ethyl-N-nitrosourea (ENU) in rats. Vet Pathol 1985;22:483-491. (Pubitemid 15225716)
39. Liebelt AG, Sass B, Lombard LS. Mouse ovarian tumorsVa review including classification and induction of neoplastic lesions and description of several previously unreported types. J Exp Pathol 1987;3:115-145.
40. Okamura H, Katabuchi H. Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability. Ital J Anat Embryol 2001;106:263-276.
41. Brodowska A, Laszczynska M, Starczewski A, Karakiewicz B, Brodowski J. The localization of estrogen receptor α and its function in the ovaries of postmenopausal women. Folia Histochem Cytobiol 2007;45:325-330. (Pubitemid 351193605)